nodes	percent_of_prediction	percent_of_DWPC	metapath
Trifluridine—TK1—Validated targets of C-MYC transcriptional activation—PRDX3—osteoporosis	0.0618	0.0782	CbGpPWpGaD
Trifluridine—TK1—Nucleotide metabolism—PNP—osteoporosis	0.0571	0.0722	CbGpPWpGaD
Trifluridine—TK1—Nucleotide metabolism—ATIC—osteoporosis	0.0571	0.0722	CbGpPWpGaD
Trifluridine—Cladribine—PNP—osteoporosis	0.0515	1	CrCbGaD
Trifluridine—TYMS—One Carbon Metabolism—ATIC—osteoporosis	0.046	0.0581	CbGpPWpGaD
Trifluridine—TYMP—Nucleotide metabolism—PNP—osteoporosis	0.0396	0.0501	CbGpPWpGaD
Trifluridine—TYMP—Nucleotide metabolism—ATIC—osteoporosis	0.0396	0.0501	CbGpPWpGaD
Trifluridine—TK1—Validated targets of C-MYC transcriptional activation—GAPDH—osteoporosis	0.0313	0.0395	CbGpPWpGaD
Trifluridine—TK1—Fluoropyrimidine Activity—MTHFR—osteoporosis	0.0297	0.0376	CbGpPWpGaD
Trifluridine—TK1—Validated targets of C-MYC transcriptional activation—ENO1—osteoporosis	0.0246	0.0311	CbGpPWpGaD
Trifluridine—TYMP—Fluoropyrimidine Activity—MTHFR—osteoporosis	0.0206	0.0261	CbGpPWpGaD
Trifluridine—TYMS—Nucleotide metabolism—PNP—osteoporosis	0.0203	0.0256	CbGpPWpGaD
Trifluridine—TYMS—Nucleotide metabolism—ATIC—osteoporosis	0.0203	0.0256	CbGpPWpGaD
Trifluridine—Stinging—Calcium Acetate—osteoporosis	0.0185	0.152	CcSEcCtD
Trifluridine—TYMS—Circadian rythm related genes—ID4—osteoporosis	0.0181	0.0229	CbGpPWpGaD
Trifluridine—TYMS—Levorphanol—Estradiol—osteoporosis	0.0168	0.469	CbGdCrCtD
Trifluridine—TK1—Nucleotide metabolism—GPX1—osteoporosis	0.0162	0.0205	CbGpPWpGaD
Trifluridine—TYMS—One Carbon Metabolism—MTHFR—osteoporosis	0.012	0.0152	CbGpPWpGaD
Trifluridine—TYMP—Nucleotide metabolism—GPX1—osteoporosis	0.0112	0.0142	CbGpPWpGaD
Trifluridine—TYMS—Danazol—Ethinyl Estradiol—osteoporosis	0.0111	0.309	CbGdCrCtD
Trifluridine—TYMS—Trans-sulfuration and one carbon metabolism—MTHFR—osteoporosis	0.0108	0.0137	CbGpPWpGaD
Trifluridine—TYMS—Fluoropyrimidine Activity—MTHFR—osteoporosis	0.0105	0.0133	CbGpPWpGaD
Trifluridine—TYMP—Bladder Cancer—MYC—osteoporosis	0.01	0.0127	CbGpPWpGaD
Trifluridine—Eyelid oedema—Estradiol—osteoporosis	0.00891	0.0733	CcSEcCtD
Trifluridine—TYMS—Levonorgestrel—Ethinyl Estradiol—osteoporosis	0.00794	0.222	CbGdCrCtD
Trifluridine—TK1—E2F transcription factor network—MYC—osteoporosis	0.00728	0.00921	CbGpPWpGaD
Trifluridine—TK1—Validated targets of C-MYC transcriptional activation—MYC—osteoporosis	0.00684	0.00864	CbGpPWpGaD
Trifluridine—TYMS—G1/S Transition—PSMA2—osteoporosis	0.00665	0.00841	CbGpPWpGaD
Trifluridine—TYMS—G1/S Transition—PSMA5—osteoporosis	0.00665	0.00841	CbGpPWpGaD
Trifluridine—Dry eye—Risedronate—osteoporosis	0.00621	0.051	CcSEcCtD
Trifluridine—TK1—Metabolism—FDPS—osteoporosis	0.00599	0.00757	CbGpPWpGaD
Trifluridine—TK1—Metabolism—PKM—osteoporosis	0.00599	0.00757	CbGpPWpGaD
Trifluridine—TYMS—Nucleotide metabolism—GPX1—osteoporosis	0.00574	0.00726	CbGpPWpGaD
Trifluridine—TK1—Metabolism—GPD2—osteoporosis	0.00568	0.00717	CbGpPWpGaD
Trifluridine—TK1—Metabolism—PGLS—osteoporosis	0.00568	0.00717	CbGpPWpGaD
Trifluridine—TYMS—Mitotic G1-G1/S phases—PSMA2—osteoporosis	0.0056	0.00708	CbGpPWpGaD
Trifluridine—TYMS—Mitotic G1-G1/S phases—PSMA5—osteoporosis	0.0056	0.00708	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	0.00533	0.00674	CbGpPWpGaD
Trifluridine—TK1—Metabolism—ATIC—osteoporosis	0.00519	0.00656	CbGpPWpGaD
Trifluridine—TK1—Metabolism—PNP—osteoporosis	0.00519	0.00656	CbGpPWpGaD
Trifluridine—Pain—Calcium Acetate—osteoporosis	0.00457	0.0376	CcSEcCtD
Trifluridine—TK1—Metabolism—OXCT1—osteoporosis	0.00441	0.00558	CbGpPWpGaD
Trifluridine—TK1—Metabolism—CA2—osteoporosis	0.00441	0.00558	CbGpPWpGaD
Trifluridine—TK1—Metabolism—MGLL—osteoporosis	0.0043	0.00544	CbGpPWpGaD
Trifluridine—Dry eye—Estradiol—osteoporosis	0.00415	0.0342	CcSEcCtD
Trifluridine—TYMP—Metabolism—PKM—osteoporosis	0.00415	0.00525	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—FDPS—osteoporosis	0.00415	0.00525	CbGpPWpGaD
Trifluridine—Pain—Ergocalciferol—osteoporosis	0.00403	0.0332	CcSEcCtD
Trifluridine—Hypersensitivity—Calcium Acetate—osteoporosis	0.00393	0.0324	CcSEcCtD
Trifluridine—TYMP—Metabolism—PGLS—osteoporosis	0.00393	0.00497	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—GPD2—osteoporosis	0.00393	0.00497	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	0.00379	0.00479	CbGpPWpGaD
Trifluridine—TK1—Metabolism—IDH2—osteoporosis	0.00366	0.00462	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—PNP—osteoporosis	0.0036	0.00455	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—ATIC—osteoporosis	0.0036	0.00455	CbGpPWpGaD
Trifluridine—TK1—Metabolism—CYP27A1—osteoporosis	0.00344	0.00435	CbGpPWpGaD
Trifluridine—TK1—Metabolism—ACP5—osteoporosis	0.00335	0.00423	CbGpPWpGaD
Trifluridine—Nausea—Calcium Acetate—osteoporosis	0.00317	0.0261	CcSEcCtD
Trifluridine—TK1—Metabolism—TPI1—osteoporosis	0.00311	0.00393	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—CA2—osteoporosis	0.00306	0.00387	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—OXCT1—osteoporosis	0.00306	0.00387	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—MGLL—osteoporosis	0.00298	0.00377	CbGpPWpGaD
Trifluridine—TK1—Metabolism—P4HB—osteoporosis	0.00292	0.0037	CbGpPWpGaD
Trifluridine—TK1—Metabolism—GAPDH—osteoporosis	0.00287	0.00363	CbGpPWpGaD
Trifluridine—Nausea—Ergocalciferol—osteoporosis	0.0028	0.023	CcSEcCtD
Trifluridine—TK1—Metabolism—RAP1A—osteoporosis	0.0028	0.00353	CbGpPWpGaD
Trifluridine—Pain—Estropipate—osteoporosis	0.00259	0.0213	CcSEcCtD
Trifluridine—Hypersensitivity—Etidronic acid—osteoporosis	0.00258	0.0212	CcSEcCtD
Trifluridine—TYMS—E2F transcription factor network—MYC—osteoporosis	0.00258	0.00326	CbGpPWpGaD
Trifluridine—Pain—Alendronate—osteoporosis	0.00255	0.021	CcSEcCtD
Trifluridine—TYMP—Metabolism—IDH2—osteoporosis	0.00254	0.0032	CbGpPWpGaD
Trifluridine—Pain—Raloxifene—osteoporosis	0.00251	0.0207	CcSEcCtD
Trifluridine—Pain—Ibandronate—osteoporosis	0.00249	0.0205	CcSEcCtD
Trifluridine—Pain—Calcitriol—osteoporosis	0.00243	0.02	CcSEcCtD
Trifluridine—Vision blurred—Zoledronate—osteoporosis	0.0024	0.0198	CcSEcCtD
Trifluridine—TYMP—Metabolism—CYP27A1—osteoporosis	0.00238	0.00301	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—ACP5—osteoporosis	0.00232	0.00293	CbGpPWpGaD
Trifluridine—Vision blurred—Conjugated Estrogens—osteoporosis	0.00231	0.019	CcSEcCtD
Trifluridine—TYMS—Circadian rythm related genes—LEP—osteoporosis	0.00231	0.00292	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	0.0023	0.00291	CbGpPWpGaD
Trifluridine—TK1—Metabolism—ENO1—osteoporosis	0.00226	0.00286	CbGpPWpGaD
Trifluridine—TYMS—Retinoblastoma (RB) in Cancer—MYC—osteoporosis	0.00224	0.00284	CbGpPWpGaD
Trifluridine—Hypersensitivity—Estropipate—osteoporosis	0.00223	0.0184	CcSEcCtD
Trifluridine—TK1—Metabolism—PSMA2—osteoporosis	0.00223	0.00281	CbGpPWpGaD
Trifluridine—TK1—Metabolism—PSMA5—osteoporosis	0.00223	0.00281	CbGpPWpGaD
Trifluridine—Hypersensitivity—Alendronate—osteoporosis	0.0022	0.0181	CcSEcCtD
Trifluridine—TYMP—Metabolism—TPI1—osteoporosis	0.00216	0.00272	CbGpPWpGaD
Trifluridine—Hypersensitivity—Ibandronate—osteoporosis	0.00214	0.0176	CcSEcCtD
Trifluridine—TYMS—Metabolism—FDPS—osteoporosis	0.00212	0.00268	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—PKM—osteoporosis	0.00212	0.00268	CbGpPWpGaD
Trifluridine—Hypersensitivity—Calcitriol—osteoporosis	0.0021	0.0173	CcSEcCtD
Trifluridine—Nausea—Etidronic acid—osteoporosis	0.00208	0.0171	CcSEcCtD
Trifluridine—TYMS—Cell Cycle, Mitotic—PSMA5—osteoporosis	0.00206	0.0026	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—PSMA2—osteoporosis	0.00206	0.0026	CbGpPWpGaD
Trifluridine—Pain—Risedronate—osteoporosis	0.00205	0.0169	CcSEcCtD
Trifluridine—TYMP—Metabolism—P4HB—osteoporosis	0.00203	0.00256	CbGpPWpGaD
Trifluridine—SLC22A6—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.00202	0.00255	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—PGLS—osteoporosis	0.00201	0.00254	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—GPD2—osteoporosis	0.00201	0.00254	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	0.00199	0.00252	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—GAPDH—osteoporosis	0.00199	0.00251	CbGpPWpGaD
Trifluridine—Pain—Pamidronate—osteoporosis	0.00195	0.016	CcSEcCtD
Trifluridine—TYMP—Metabolism—RAP1A—osteoporosis	0.00194	0.00245	CbGpPWpGaD
Trifluridine—TYMS—G1/S Transition—MYC—osteoporosis	0.00187	0.00237	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—ATIC—osteoporosis	0.00184	0.00233	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—PNP—osteoporosis	0.00184	0.00233	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—PSMA2—osteoporosis	0.00184	0.00232	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—PSMA5—osteoporosis	0.00184	0.00232	CbGpPWpGaD
Trifluridine—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00181	0.0149	CcSEcCtD
Trifluridine—TK1—Metabolism—CYP19A1—osteoporosis	0.00181	0.00228	CbGpPWpGaD
Trifluridine—Nausea—Estropipate—osteoporosis	0.0018	0.0148	CcSEcCtD
Trifluridine—Pain—Zoledronate—osteoporosis	0.00178	0.0146	CcSEcCtD
Trifluridine—Nausea—Alendronate—osteoporosis	0.00177	0.0146	CcSEcCtD
Trifluridine—Hypersensitivity—Risedronate—osteoporosis	0.00177	0.0145	CcSEcCtD
Trifluridine—Nausea—Raloxifene—osteoporosis	0.00175	0.0144	CcSEcCtD
Trifluridine—Nausea—Ibandronate—osteoporosis	0.00173	0.0142	CcSEcCtD
Trifluridine—Pain—Conjugated Estrogens—osteoporosis	0.00171	0.0141	CcSEcCtD
Trifluridine—Nausea—Calcitriol—osteoporosis	0.00169	0.0139	CcSEcCtD
Trifluridine—Hypersensitivity—Pamidronate—osteoporosis	0.00168	0.0138	CcSEcCtD
Trifluridine—TYMS—Mitotic G1-G1/S phases—MYC—osteoporosis	0.00158	0.002	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—ENO1—osteoporosis	0.00157	0.00198	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—CA2—osteoporosis	0.00157	0.00198	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—OXCT1—osteoporosis	0.00157	0.00198	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—PSMA5—osteoporosis	0.00154	0.00195	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—PSMA2—osteoporosis	0.00154	0.00195	CbGpPWpGaD
Trifluridine—Hypersensitivity—Zoledronate—osteoporosis	0.00153	0.0126	CcSEcCtD
Trifluridine—TYMS—Metabolism—MGLL—osteoporosis	0.00153	0.00193	CbGpPWpGaD
Trifluridine—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.00148	0.0121	CcSEcCtD
Trifluridine—TK1—Metabolism—ADCY5—osteoporosis	0.00148	0.00187	CbGpPWpGaD
Trifluridine—TK1—Metabolism—GPX1—osteoporosis	0.00147	0.00186	CbGpPWpGaD
Trifluridine—Nausea—Ethinyl Estradiol—osteoporosis	0.00146	0.012	CcSEcCtD
Trifluridine—Nausea—Risedronate—osteoporosis	0.00142	0.0117	CcSEcCtD
Trifluridine—Pain—Estradiol—osteoporosis	0.00137	0.0113	CcSEcCtD
Trifluridine—TK1—Metabolism—MTHFR—osteoporosis	0.00136	0.00172	CbGpPWpGaD
Trifluridine—Nausea—Pamidronate—osteoporosis	0.00135	0.0111	CcSEcCtD
Trifluridine—TYMS—Metabolism—IDH2—osteoporosis	0.0013	0.00164	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—CYP19A1—osteoporosis	0.00125	0.00158	CbGpPWpGaD
Trifluridine—Nausea—Zoledronate—osteoporosis	0.00124	0.0102	CcSEcCtD
Trifluridine—TYMS—Metabolism—CYP27A1—osteoporosis	0.00122	0.00154	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	0.0012	0.00151	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	0.00119	0.00151	CbGpPWpGaD
Trifluridine—Nausea—Conjugated Estrogens—osteoporosis	0.00119	0.00979	CcSEcCtD
Trifluridine—TYMS—Metabolism—ACP5—osteoporosis	0.00119	0.0015	CbGpPWpGaD
Trifluridine—Hypersensitivity—Estradiol—osteoporosis	0.00118	0.00972	CcSEcCtD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	0.00111	0.00141	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—TPI1—osteoporosis	0.0011	0.00139	CbGpPWpGaD
Trifluridine—TK1—Metabolism—POMC—osteoporosis	0.00109	0.00137	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—P4HB—osteoporosis	0.00104	0.00131	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—ADCY5—osteoporosis	0.00102	0.00129	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—GPX1—osteoporosis	0.00102	0.00129	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—GAPDH—osteoporosis	0.00102	0.00129	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—RAP1A—osteoporosis	0.000991	0.00125	CbGpPWpGaD
Trifluridine—Nausea—Estradiol—osteoporosis	0.000953	0.00784	CcSEcCtD
Trifluridine—TYMP—Metabolism—MTHFR—osteoporosis	0.000941	0.00119	CbGpPWpGaD
Trifluridine—TYMS—Circadian rythm related genes—IL6—osteoporosis	0.000863	0.00109	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—ENO1—osteoporosis	0.000801	0.00101	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—PSMA5—osteoporosis	0.000789	0.000998	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—PSMA2—osteoporosis	0.000789	0.000998	CbGpPWpGaD
Trifluridine—SLC22A6—Transmembrane transport of small molecules—ADCY5—osteoporosis	0.000757	0.000957	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—POMC—osteoporosis	0.000752	0.000951	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—CYP19A1—osteoporosis	0.000641	0.00081	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—MYC—osteoporosis	0.000579	0.000732	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—ADCY5—osteoporosis	0.000523	0.000662	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—GPX1—osteoporosis	0.000522	0.000659	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—MYC—osteoporosis	0.000518	0.000655	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—MTHFR—osteoporosis	0.000481	0.000608	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—POMC—osteoporosis	0.000385	0.000487	CbGpPWpGaD
